Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm

Autor: Renaud Du Pasquier, Jean-Philippe Brouland, Denis Comte, Vincent Dunet, Patrizia Comoli, Olivier Spertini, Yordanka Tirefort, Sabine Blum, Françoise Livio, Onya Opota, Yves Chalandon
Rok vydání: 2020
Předmět:
Cancer Research
Pathology
medicine.medical_specialty
Receptor
Platelet-Derived Growth Factor alpha
Humans Hypereosinophilic Syndrome* Imatinib Mesylate / therapeutic use Leukoencephalopathy
Oncogene Proteins
Fusion
Opportunistic infection
Central nervous system
macromolecular substances
Myeloid Neoplasm
03 medical and health sciences
0302 clinical medicine
Neoplasms
Platelet-Derived Growth Factor alpha / metabolism mRNA Cleavage and Polyadenylation Factors / genetics
parasitic diseases
Hypereosinophilic Syndrome
Fusion / genetics Oncogene Proteins
Medicine
Humans
ddc:616
Platelet-Derived Growth Factor alpha / genetics Receptor
mRNA Cleavage and Polyadenylation Factors
Progressive Multifocal* / diagnosis Leukoencephalopathy
Myeloproliferative Disorders
business.industry
Progressive multifocal leukoencephalopathy
Leukoencephalopathy
Progressive Multifocal
Imatinib
Progressive Multifocal* / drug therapy Myeloproliferative Disorders* / complications Myeloproliferative Disorders* / diagnosis Myeloproliferative Disorders* / drug therapy Neoplasms* Oncogene Proteins
Hematology
medicine.disease
humanities
Fip1l1 pdgfra
medicine.anatomical_structure
Oncology
030220 oncology & carcinogenesis
Imatinib Mesylate
Fusion / metabolism Receptor
business
Complication
030215 immunology
medicine.drug
Zdroj: Leukemia and Lymphoma, Vol. 61, No 9 (2020) pp. 2226-2229
ISSN: 1029-2403
1026-8022
Popis: Progressive multifocal leukoencephalopathy (PML) is a severe demyelinating, mostly lethal complication due to an opportunistic infection of the central nervous system (CNS) by John Cunningham polyo...
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje